2022 Q1 Form 10-K Financial Statement

#000143774922021365 Filed on August 26, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $0.00 $324.2K $0.00
YoY Change
Cost Of Revenue $0.00 $110.0K
YoY Change
Gross Profit $0.00 $215.0K
YoY Change
Gross Profit Margin 66.3%
Selling, General & Admin $56.61M $59.00M $620.0K
YoY Change 9030.65% 9416.13%
% of Gross Profit 27443.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $56.60M $59.00M $620.0K
YoY Change 9029.03% 9375.47%
Operating Profit -$56.60M -$58.79M
YoY Change 9340.94%
Interest Expense $0.00 $13.41K $40.00K
YoY Change -100.0% -52.54% -233.33%
% of Operating Profit
Other Income/Expense, Net $3.180M $11.18M -$6.810M
YoY Change -146.7% -264.12%
Pretax Income -$53.35M -$47.60M -$7.390M
YoY Change 621.92% 540.06% 4005.56%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$53.35M -$47.60M -$7.390M
YoY Change 621.92% 540.06% 4005.56%
Net Earnings / Revenue -14681.73%
Basic Earnings Per Share -$1.04
Diluted Earnings Per Share -$222.30 -$153.50 -$23.09
COMMON SHARES
Basic Shares Outstanding 48.49M 45.80M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.370M $6.370M $1.970M
YoY Change 223.35% 223.35%
Cash & Equivalents $6.367M $6.370M $1.970M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $120.0K $120.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.485M $6.490M $1.970M
YoY Change 229.27% 229.44% 4190342.55%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.01M $12.01M $1.200M
YoY Change 900.83% 900.83%
Total Long-Term Assets $12.01M $12.00M $1.200M
YoY Change 900.42% 900.0%
TOTAL ASSETS
Total Short-Term Assets $6.485M $6.490M $1.970M
Total Long-Term Assets $12.01M $12.00M $1.200M
Total Assets $18.49M $18.49M $3.170M
YoY Change 483.37% 483.28% 6743534.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $380.0K $380.0K $530.0K
YoY Change -28.3% -28.3% 65.63%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $120.0K $120.0K $250.0K
YoY Change -52.0% -52.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.01M $21.01M $11.52M
YoY Change 82.36% 1827.52% 1162.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $21.01M $21.01M $11.52M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $21.01M $21.01M $11.52M
YoY Change 82.36% 1827.52% 1162.11%
SHAREHOLDERS EQUITY
Retained Earnings -$67.45M -$19.85M
YoY Change 239.84% 59.93%
Common Stock $332.00 $323.00
YoY Change 2.79% -99.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $186.00 $0.00
YoY Change
Treasury Stock Shares $186.1K $186.1K
Shareholders Equity -$2.517M -$2.520M -$8.350M
YoY Change
Total Liabilities & Shareholders Equity $18.49M $18.49M $3.170M
YoY Change 483.37% 483.28% 6743534.04%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income -$53.35M -$47.60M -$7.390M
YoY Change 621.92% 540.06% 4005.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.090M -$3.426M -$210.0K
YoY Change 419.05% 1528.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.730M -$11.62M -$1.200M
YoY Change 127.5% 868.33%
Cash From Investing Activities -$2.730M -$11.62M -$1.200M
YoY Change 127.5% 868.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.020M $19.44M 3.380M
YoY Change -40.24% 475.22% -33900.0%
NET CHANGE
Cash From Operating Activities -1.090M -$3.426M -210.0K
Cash From Investing Activities -2.730M -$11.62M -1.200M
Cash From Financing Activities 2.020M $19.44M 3.380M
Net Change In Cash -1.800M $4.397M 1.970M
YoY Change -191.37% 123.27% -19800.0%
FREE CASH FLOW
Cash From Operating Activities -$1.090M -$3.426M -$210.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 qegy Common Stock Payable Deposits Received On Subscriptions Agreements Unrealized Loss
CommonStockPayableDepositsReceivedOnSubscriptionsAgreementsUnrealizedLoss
-5748276 usd
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48491485
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18490088 usd
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3169508 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324240 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2022Q1 qegy Common Stock Payable Contract Agreements Fair Value Of Shares
CommonStockPayableContractAgreementsFairValueOfShares
1610107 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1816320 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
240467 usd
CY2021 qegy Common Stock Payable Contract Agreements Unrealized Gain
CommonStockPayableContractAgreementsUnrealizedGain
-1060000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
59003351 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
622696 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-58788364 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-622696 usd
CY2022 qegy Gain Loss On Debt Conversion
GainLossOnDebtConversion
221268 usd
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
21787 usd
CY2022 qegy Common Stock Payable Unrealized Gain
CommonStockPayableUnrealizedGain
10616456 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 qegy Common Stock Payable Unrealized Gain
CommonStockPayableUnrealizedGain
-6808276 usd
CY2022 qegy Common Stock Payable Realized Gain
CommonStockPayableRealizedGain
360000 usd
CY2022 us-gaap Interest Expense
InterestExpense
13411 usd
CY2021 us-gaap Interest Expense
InterestExpense
28257 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11184313 usd
CY2021Q1 us-gaap Liabilities
Liabilities
11519633 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6814746 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47604051 usd
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7437442 usd
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
495000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
332324
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
323277
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
323277
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
332324
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-47604051 usd
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
323277
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7437442 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45798221
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48491485
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
332 usd
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
323 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2022 qegy Common Stock Subscribed For Rent
CommonStockSubscribedForRent
0 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64933850 usd
CY2021 qegy Common Stock Subscribed For Rent
CommonStockSubscribedForRent
240000 usd
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11497849 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67452348 usd
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19848297 usd
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
186096
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
186096
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
186 usd
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
-0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2517437 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-0 usd
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
21787 usd
CY2022 qegy Common Stock Payable Unrealized Gain
CommonStockPayableUnrealizedGain
10616456 usd
CY2021 qegy Common Stock Payable Unrealized Gain
CommonStockPayableUnrealizedGain
-6808276 usd
CY2022 qegy Gain Loss On Debt Conversion
GainLossOnDebtConversion
221268 usd
CY2021 qegy Gain Loss On Debt Conversion
GainLossOnDebtConversion
-0 usd
CY2022 qegy Common Stock Payable Realized Gain
CommonStockPayableRealizedGain
360000 usd
CY2021 qegy Common Stock Payable Realized Gain
CommonStockPayableRealizedGain
-0 usd
CY2022 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
118358 usd
CY2021 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-0 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-8350125 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30065 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022Q1 qegy Common Stock Voting Rights Number Of Votes Per Share
CommonStockVotingRightsNumberOfVotesPerShare
1 pure
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001295961
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 qegy Class Of Warrant Or Right Remaining Term
ClassOfWarrantOrRightRemainingTerm
P0Y29D
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-02-28
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-225892
CY2022 dei Entity Registrant Name
EntityRegistrantName
Quantum Energy Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0428608
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3825 Rockbottom
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
North Las Vegas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89030
CY2022 dei City Area Code
CityAreaCode
702
CY2022 dei Local Phone Number
LocalPhoneNumber
323-6455
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.001 Par Value
CY2022 dei Trading Symbol
TradingSymbol
QEGY
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021Q4 dei Entity Public Float
EntityPublicFloat
1260969 usd
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q1 us-gaap Cash
Cash
6366730 usd
CY2022Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
118358 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
6485088 usd
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1969508 usd
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12005000 usd
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1200000 usd
CY2022Q1 us-gaap Assets
Assets
18490088 usd
CY2021Q1 us-gaap Assets
Assets
3169508 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
166080 usd
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
220140 usd
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
217584 usd
CY2021Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
305170 usd
CY2022Q1 qegy Common Stock Payable Current For Contracts Agreements Current
CommonStockPayableCurrentForContractsAgreementsCurrent
1990107 usd
CY2021Q1 qegy Common Stock Payable Current For Contracts Agreements Current
CommonStockPayableCurrentForContractsAgreementsCurrent
1500000 usd
CY2022Q1 qegy Common Stock Payable For Deposit Received On Subscription Agreements Current
CommonStockPayableForDepositReceivedOnSubscriptionAgreementsCurrent
18515734 usd
CY2021Q1 qegy Common Stock Payable For Deposit Received On Subscription Agreements Current
CommonStockPayableForDepositReceivedOnSubscriptionAgreementsCurrent
9128104 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
67500 usd
CY2021Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
116399 usd
CY2022Q1 qegy Promissory Notes Payable Current
PromissoryNotesPayableCurrent
76305 usd
CY2021Q1 qegy Promissory Notes Payable Current
PromissoryNotesPayableCurrent
76305 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
41715 usd
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
106015 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21007525 usd
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11519633 usd
CY2022Q1 us-gaap Liabilities
Liabilities
21007525 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
72253 usd
CY2022 qegy Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
-71013 usd
CY2021 qegy Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
128333 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3426104 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-210367 usd
CY2022 qegy Payment For Purchase Of Treasury Stock
PaymentForPurchaseOfTreasuryStock
813261 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10805000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1200000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11618261 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1200000 usd
CY2022 qegy Reimbursement For Cash Of Common Stock
ReimbursementForCashOfCommonStock
25000 usd
CY2021 qegy Reimbursement For Cash Of Common Stock
ReimbursementForCashOfCommonStock
0 usd
CY2022 qegy Proceeds From Stock Payable
ProceedsFromStockPayable
19484087 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
67500 usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19441587 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3379828 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4397222 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1969461 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1969508 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6366730 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1969508 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2500 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-912683 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7437442 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-8350125 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-8350125 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53985000 usd
CY2022 qegy Purchase Of Common Stock Value
PurchaseOfCommonStockValue
25000 usd
CY2022 qegy Common Stock Issued From Subscriptions Value
CommonStockIssuedFromSubscriptionsValue
240000 usd
CY2022 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
813261 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-47604051 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2517437 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 54pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>NOTE 1 - </b></p> </td> <td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>NATURE OF OPERATIONS</b></p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">QUANTUM ENERGY INC. (“the Company”) was incorporated under the name “Boomers Cultural Development Inc.” under the laws of the State of Nevada on February 5, 2004. On May 18, 2006, the Company changed its name to Quantum Energy, Inc.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is a development stage diversified holding company with an emphasis in land holdings, refinery and fuel distribution.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is domiciled in the Unites States of America and trades on the OTC market under the symbol QEGY.</p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<span style="text-decoration: underline; ">Use of Estimates</span> The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1925000
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2925000
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1925000
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3925000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
118358 usd
CY2022Q1 qegy Related Party Purchase Of Shares Agreement Price Per Share
RelatedPartyPurchaseOfSharesAgreementPricePerShare
2.10
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12005000 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
76305 usd
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
76305 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
41715 usd
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
106015 usd
CY2021Q2 qegy Common Stock Payable Contract Agreements Fair Value Of Shares
CommonStockPayableContractAgreementsFairValueOfShares
600000 usd
CY2021Q2 qegy Common Stock Payable Contract Agreements Unrealized Gain
CommonStockPayableContractAgreementsUnrealizedGain
150000 usd
CY2021Q2 qegy Common Stock Payable Gain On Issuance Of Shares
CommonStockPayableGainOnIssuanceOfShares
360000 usd
CY2022 qegy Common Stock Payable Contract Agreements Unrealized Gain
CommonStockPayableContractAgreementsUnrealizedGain
370000 usd
CY2022Q1 qegy Common Stock Payable Shares Contract Agreements
CommonStockPayableSharesContractAgreements
3354037
CY2022 qegy Common Stock Payabledeposits Received On Subscriptions Agreements Unrealized Gain
CommonStockPayabledepositsReceivedOnSubscriptionsAgreementsUnrealizedGain
10246456 usd
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
495000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 qegy Preferred Stock Voting Rights Number Of Votes Per Share
PreferredStockVotingRightsNumberOfVotesPerShare
100 pure
CY2022Q1 us-gaap Share Price
SharePrice
0.59
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
27914411
CY2022 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
813261 usd
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
150 pure
CY2022 qegy Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
1000000
CY2021 qegy Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
1000000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1925000
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2925000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1925000
CY2022Q1 qegy Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1925000

Files In Submission

Name View Source Status
0001437749-22-021365-index-headers.html Edgar Link pending
0001437749-22-021365-index.html Edgar Link pending
0001437749-22-021365.txt Edgar Link pending
0001437749-22-021365-xbrl.zip Edgar Link pending
ex_398258.htm Edgar Link pending
ex_398259.htm Edgar Link pending
ex_398260.htm Edgar Link pending
ex_398261.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qegy-20220228.xsd Edgar Link pending
qegy20220228_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
qegy-20220228_def.xml Edgar Link unprocessable
qegy-20220228_pre.xml Edgar Link unprocessable
qegy-20220228_lab.xml Edgar Link unprocessable
qegy-20220228_cal.xml Edgar Link unprocessable
qegy20220228_10k_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable